Figures & data
Figure 1 Evolution of transepidermal water loss (TEWL). *P=0.002; Wilcoxon test.
![Figure 1 Evolution of transepidermal water loss (TEWL). *P=0.002; Wilcoxon test.](/cms/asset/9ed15be3-9dbe-4a98-87da-4c333fc6dea4/dcci_a_12161527_f0001_b.jpg)
Figure 2 Evolution of dark spots evaluated with colorimetry; *P=0.0021; Wilcoxon test. Abbreviation: ITA, Individual Typology Angle.
![Figure 2 Evolution of dark spots evaluated with colorimetry; *P=0.0021; Wilcoxon test. Abbreviation: ITA, Individual Typology Angle.](/cms/asset/415b6ce0-ead4-4f23-b10a-3099bf778330/dcci_a_12161527_f0002_b.jpg)
Figure 3 Evolution of SQOOH/SQ ratio. *P=0.017; Wilcoxon test.
![Figure 3 Evolution of SQOOH/SQ ratio. *P=0.017; Wilcoxon test.](/cms/asset/3e7c9e49-ae2f-437a-87f9-10ada5811d79/dcci_a_12161527_f0003_b.jpg)
Figure 4 High-resolution pictures of two subjects evaluating dark spots (A and A1: baseline, D0; B and B1: after treatment D28).
![Figure 4 High-resolution pictures of two subjects evaluating dark spots (A and A1: baseline, D0; B and B1: after treatment D28).](/cms/asset/dde73a47-93be-4b0b-a2ff-5998e3c3e9c6/dcci_a_12161527_f0004_c.jpg)
Table 1 Subjects’ characteristics at baseline
Table 2 Data analysis of outcomes variables